Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lisa A Santry

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Plos One|April 12, 2014
Opposing functions of Akt isoforms in lung tumor initiation and progressionNicolle M Linnerth-Petrik, Lisa A Santry, James J Petrik, et al.
Plos One|December 20, 2012
Adeno-associated virus vector mediated expression of an oncogenic retroviral envelope protein induces lung adenocarcinomas in immunocompetent miceNicolle M Linnerth-Petrik, Lisa A Santry, Darrick L Yu, et al.
Oncotarget|August 18, 2016
Akt isoform specific effects in ovarian cancer progressionNicolle M Linnerth-Petrik, Lisa A Santry, Roger Moorehead, et al.
Virus Research|April 16, 2013
Genetic characterization of small ruminant lentiviruses circulating in naturally infected sheep and goats in Ontario, CanadaLisa A Santry, Jondavid de Jong, Alexander C Gold, et al.
The Journal of General Virology|December 1, 2016
Truncation of the enzootic nasal tumor virus envelope protein cytoplasmic tail increases Env-mediated fusion and infectivityScott R Walsh, Jondavid G de Jong, Jacob P van Vloten, et al.
BMC Biotechnology|May 17, 2017
AAV vector distribution in the mouse respiratory tract following four different methods of administrationLisa A Santry, Joelle C Ingrao, Darrick L Yu, et al.
Molecular Therapy. Methods & Clinical Development|March 21, 2018
Production and Purification of High-Titer Newcastle Disease Virus for Use in Preclinical Mouse Models of CancerLisa A Santry, Thomas M McAusland, Leonardo Susta, et al.
Molecular Therapy. Methods & Clinical Development|February 22, 2019
Quantifying Antigen-Specific T Cell Responses When Using Antigen-Agnostic ImmunotherapiesJacob P van Vloten, Lisa A Santry, Thomas M McAusland, et al.
Gene Therapy|February 20, 2021
AAV-mediated delivery of actoxumab and bezlotoxumab results in serum and mucosal antibody concentrations that provide protection from C. difficile toxin challengeMatthew M Guilleman, Brenna A Y Stevens, Laura P Van Lieshout, et al.
Gynecologic Oncology|November 20, 2021
Addition of an Fc-IgG induces receptor clustering and increases the in vitro efficacy and in vivo anti-tumor properties of the thrombospondin-1 type I repeats (3TSR) in a mouse model of advanced stage ovarian cancerKathy Matuszewska, Simone Ten Kortenaar, Madison Pereira, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Plos One|April 12, 2014
Opposing functions of Akt isoforms in lung tumor initiation and progressionNicolle M Linnerth-Petrik, Lisa A Santry, James J Petrik, et al.
Plos One|December 20, 2012
Adeno-associated virus vector mediated expression of an oncogenic retroviral envelope protein induces lung adenocarcinomas in immunocompetent miceNicolle M Linnerth-Petrik, Lisa A Santry, Darrick L Yu, et al.
Oncotarget|August 18, 2016
Akt isoform specific effects in ovarian cancer progressionNicolle M Linnerth-Petrik, Lisa A Santry, Roger Moorehead, et al.
Virus Research|April 16, 2013
Genetic characterization of small ruminant lentiviruses circulating in naturally infected sheep and goats in Ontario, CanadaLisa A Santry, Jondavid de Jong, Alexander C Gold, et al.
The Journal of General Virology|December 1, 2016
Truncation of the enzootic nasal tumor virus envelope protein cytoplasmic tail increases Env-mediated fusion and infectivityScott R Walsh, Jondavid G de Jong, Jacob P van Vloten, et al.
BMC Biotechnology|May 17, 2017
AAV vector distribution in the mouse respiratory tract following four different methods of administrationLisa A Santry, Joelle C Ingrao, Darrick L Yu, et al.
Molecular Therapy. Methods & Clinical Development|March 21, 2018
Production and Purification of High-Titer Newcastle Disease Virus for Use in Preclinical Mouse Models of CancerLisa A Santry, Thomas M McAusland, Leonardo Susta, et al.
Molecular Therapy. Methods & Clinical Development|February 22, 2019
Quantifying Antigen-Specific T Cell Responses When Using Antigen-Agnostic ImmunotherapiesJacob P van Vloten, Lisa A Santry, Thomas M McAusland, et al.
Gene Therapy|February 20, 2021
AAV-mediated delivery of actoxumab and bezlotoxumab results in serum and mucosal antibody concentrations that provide protection from C. difficile toxin challengeMatthew M Guilleman, Brenna A Y Stevens, Laura P Van Lieshout, et al.
Gynecologic Oncology|November 20, 2021
Addition of an Fc-IgG induces receptor clustering and increases the in vitro efficacy and in vivo anti-tumor properties of the thrombospondin-1 type I repeats (3TSR) in a mouse model of advanced stage ovarian cancerKathy Matuszewska, Simone Ten Kortenaar, Madison Pereira, et al.
Pageof 3